Both in Pharmaceuticals
Celularity vs ABVC BioPharma
Over the past year CELU returned −53.0% and ABVC returned −64.5%; their daily moves had a correlation of 0.16.
CELU −53.0% ABVC −64.5%Growth of $1, one year, split-adjusted
| Metric | CELU | ABVC |
|---|---|---|
| Price | $0.8088 | $1.00 |
| Market cap | $26.2M | $26.7M |
| Today | −1.02% | +1.51% |
| 1 month | −48.8% | +3.1% |
| 6 months | −13.0% | −9.1% |
| Year to date | −27.1% | −53.1% |
| 1 year | −53.0% | −66.2% |
| Revenue growth (YoY) | −5.3% | — |
| Gross margin | 56.8% | — |
| Net margin | 10.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.4× | — |
| Net cash | -$37.1M | $34.9K |
| Dividend yield | — | — |
| Volatility (60d) | 223.1% | 77.7% |
| Short % of float | 6.7% | 2.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).